CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,222 | -92.3% | 20,806 | -89.0% | 0.00% | -89.5% |
| Q1 2023 | $3,141,827 | -49.2% | 189,495 | -43.0% | 0.02% | -47.2% |
| Q4 2022 | $6,182,900 | -24.9% | 332,414 | -48.2% | 0.04% | -21.7% |
| Q3 2022 | $8,234,000 | +231.3% | 641,800 | +81.0% | 0.05% | +206.7% |
| Q2 2022 | $2,485,000 | +0.0% | 354,519 | +18.3% | 0.02% | -28.6% |
| Q1 2022 | $2,484,000 | +7.3% | 299,595 | -12.3% | 0.02% | -4.5% |
| Q4 2021 | $2,314,000 | +288.9% | 341,762 | +204.6% | 0.02% | +214.3% |
| Q3 2021 | $595,000 | +72.5% | 112,195 | +86.8% | 0.01% | +75.0% |
| Q2 2021 | $345,000 | +148.2% | 60,055 | +99.1% | 0.00% | +100.0% |
| Q1 2021 | $139,000 | +32.4% | 30,167 | -3.7% | 0.00% | +100.0% |
| Q4 2020 | $105,000 | -11.0% | 31,333 | -20.8% | 0.00% | -50.0% |
| Q3 2020 | $118,000 | -35.9% | 39,575 | -0.5% | 0.00% | -33.3% |
| Q2 2020 | $184,000 | +80.4% | 39,787 | +46.6% | 0.00% | +50.0% |
| Q4 2019 | $102,000 | -67.5% | 27,143 | -66.8% | 0.00% | -66.7% |
| Q2 2019 | $314,000 | +912.9% | 81,806 | +537.4% | 0.01% | +200.0% |
| Q1 2018 | $31,000 | +40.9% | 12,835 | +11.6% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |